Misleading claims about AstraZeneca blood clot risk
NationalVaccine manufacturer AstraZeneca acknowledged in court documents from an ongoing lawsuit in the U.K. that the blood-clotting condition thrombocytopenia syndrome (TSS) is a rare risk associated with its COVID-19 vaccine. Vaccine opponents and some tabloid sites misleadingly framed this as a bombshell admission even though TTS has been known...